Natus Medical Incorporated (NTUS)

NASDAQ: NTUS · IEX Real-Time Price · USD
32.79
0.01 (0.03%)
May 27, 2022 10:57 AM EDT - Market open
Market Cap1.13B
Revenue (ttm)478.30M
Net Income (ttm)12.68M
Shares Out34.59M
EPS (ttm)0.38
PE Ratio87.44
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume134,799
Open32.72
Previous Close32.78
Day's Range32.68 - 32.85
52-Week Range20.90 - 33.93
Beta0.23
AnalystsSell
Price Targetn/a
Earnings DateMay 5, 2022

About NTUS

Natus Medical Incorporated provides medical device solutions focuses on the diagnosis and treatment of patients with central nervous and sensory system disorders worldwide. It offers products and technologies used for the screening, detection, treatment, monitoring, and tracking of common medical ailments in newborn care, hearing impairment, neurological and neurosurgical treatments, epilepsy, sleep disorders, and neuromuscular diseases. The company also provides computerized neurodiagnostic systems for audiology, neurology, polysomnography, an...

IndustryHealth Care Equipment & Supplies
Founded1987
CEOJonathan Kennedy
Employees1,400
Stock ExchangeNASDAQ
Ticker SymbolNTUS
Full Company Profile

Financial Performance

Financial Statements

News

The M&A Class Action Firm Continues the Investigation of Natus Medical Inc. - NTUS

New York, New York--(Newsfile Corp. - May 24, 2022) - Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC (the "M&A Class Action Firm"), a national securiti...

3 days ago - Newsfile Corp

NATUS MEDICAL INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequac...

NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Natus Medical Inco...

1 week ago - Business Wire

NATUS MEDICAL INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequac...

NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Natus Medical Inco...

3 weeks ago - Business Wire

Natus Medical Announces First Quarter 2022 Financial Results

MIDDLETON, Wis., May 05, 2022 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ:NTUS) (the “Company” or “Natus”), a leading provider of medical device solutions to screen, diagnose, and treat disor...

3 weeks ago - GlobeNewsWire

Has Natus Medical (NTUS) Outpaced Other Medical Stocks This Year?

Here is how Natus Medical (NTUS) and Option Care (OPCH) have performed compared to their sector so far this year.

3 weeks ago - Zacks Investment Research

SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates ACC, NTUS, FSI, VWTR

NEW YORK , April 26, 2022 /PRNewswire/ -- Halper Sadeh LLP, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches ...

Other symbols:ACCFSI
1 month ago - PRNewsWire

SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Natus Medical Inc. Buyout

Wilmington, Delaware--(Newsfile Corp. - April 19, 2022) - Rigrodsky Law, P.A. is investigating Natus Medical Inc. ("Natus") (NASDAQ: NTUS) regarding possible breaches of fiduciary duties and other viola...

1 month ago - Newsfile Corp

Here is why Natus Medical is up 25%

Natus Medical Incorporated (NASDAQ: NTUS) shares are up 25% after the medical device solutions provider for screening, diagnosing and treating disorders that affect the brain sensory nervous systems ad ...

1 month ago - Invezz

Why Natus Medical Stock Surged Today

A suitor wants to take the company private.

1 month ago - The Motley Fool

SHAREHOLDER ALERT: Weiss Law Investigates Natus Medical Incorporated

NEW YORK, April 18, 2022 /PRNewswire/ -- Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Natus Medical Incorporated ("Natus" or th...

1 month ago - PRNewsWire

Shareholder Alert: Wisconsin firm Ademi LLP investigates whether Natus Medical Incorporated has obtained a Fair Price...

MILWAUKEE , April 18, 2022 /PRNewswire/ -- Ademi LLP is investigating Natus (NASDAQ:NTUS) for possible breaches of fiduciary duty and other violations of law in its transaction with ArchiMed.  Click her...

1 month ago - PRNewsWire

NTUS Stock Alert: Halper Sadeh LLP Is Investigating Whether the Sale of Natus Medical Incorporated Is Fair to Shareho...

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLP, an investor rights law firm, is investigating whether the sale of Natus Medical Incorporated (NASDAQ: NTUS) to an affiliate of ArchiMed for $33.50 in cash pe...

1 month ago - Business Wire

Neurodiagnostic Focused Natus Medical Goes Private In $1.2B Deal

Natus Medical Inc (NASDAQ: NTUS) will be acquired by ArchiMed, an investment firm focused exclusively on the healthcare industry, for approximately $1.2 billion.  Natus shareholders will receive $33.50 ...

1 month ago - Benzinga

Natus Medical to be acquired at a 29% premium by ArchiMed

Natus Medical Inc. NTUS, +0.58% announced Monday a deal to be acquired in a deal valued at $1.2 billion by an affiliate of investment firm ArchiMed. Natus Medical's stock was still halted for news until...

1 month ago - Market Watch

Natus Medical to Hold 2022 First Quarter Financial Results Conference Call on May 6th

PLEASANTON, Calif., April 01, 2022 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ: NTUS), (the “Company” or “Natus”), a leading provider of medical device solutions focused on the diagnosis and ...

1 month ago - GlobeNewsWire

Is Natus Medical (NTUS) a Worthy Stock for Value Investors?

Is Natus Medical (NATUS) a great pick from the value investor's perspective right now? Read on to know more.

2 months ago - Zacks Investment Research

All You Need to Know About Natus Medical (NTUS) Rating Upgrade to Buy

Natus Medical (NTUS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

2 months ago - Zacks Investment Research

Natus Medical (NTUS) Beats Q4 Earnings and Revenue Estimates

Natus Medical (NTUS) delivered earnings and revenue surprises of 6.82% and 0.51%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

3 months ago - Zacks Investment Research

Natus Medical Announces Fourth Quarter 2021 Financial Results

PLEASANTON, Calif., Feb. 24, 2022 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ:NTUS) (the “Company” or “Natus”), a leading provider of medical device solutions to screen, diagnose, and treat d...

3 months ago - GlobeNewsWire

Natus Medical (NTUS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Natus Medical (NTUS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

3 months ago - Zacks Investment Research

Natus Announces Preliminary 2021 Fourth Quarter and Full Year Revenue

PLEASANTON, Calif., Jan. 10, 2022 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ:NTUS) (the “Company” or “Natus”), a leading provider of medical device solutions focused on the diagnosis and tre...

4 months ago - GlobeNewsWire

Natus to Participate in the 24th Annual Needham Virtual Growth Conference

PLEASANTON, Calif., Jan. 07, 2022 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ: NTUS), (the “Company” or “Natus”), a leading provider of medical device solutions focused on the diagnosis and t...

4 months ago - GlobeNewsWire

Natus Medical to Hold 2021 Fourth Quarter Financial Results Conference Call on February 25th

PLEASANTON, Calif., Jan. 03, 2022 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ: NTUS), (the “Company” or “Natus”), a leading provider of medical device solutions focused on the diagnosis and t...

4 months ago - GlobeNewsWire

Natus Medical Announces Executive Transition

Thomas J. Sullivan Appointed President & Chief Executive Officer

5 months ago - GlobeNewsWire